News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

July 1999

Hospital Expenditures and Utilization: The Impact of HMOs

ByGerard F. Anderson, PhD,Nannan Zhang, PhD,Chantal Worzala, MPA

July 1st 1999

The Cost of Alzheimer's Disease in Managed Care: A Cross-Sectional Study

ByJoel Leon, PhD,Peter Neumann, ScD

July 1st 1999

Efficacy and Cost Effectiveness of Lansoprazole Versus Omeprazole in Maintenance Treatment of Symptomatic Gastroesophageal Reflux Disease

ByEva Vivian, PharmD,Anthony Morreale, PharmD, BCPS, MBA,Eric Boyce, PharmD,Kimberly Lowry, PharmD,Oscar Ereso, PharmD,Patricia Hlavin, MD

July 1st 1999

Payor Cost Savings with Endometrial Ablation Therapy

ByRobert London, MD,Martin Holzman, MBA,Darrin Rubin, MBA,Brian Moffitt, BS

July 1st 1999

The Food and Drug Administration and Atrial Defibrillation Devices

ByLeway Chen, MD,Anne T. Keane, PA-C, JD,Nathan R. Every, MD, MPH

July 1st 1999

Benign Prostatic Hyperplasia: New Concepts for the Millennium

ByBurkhardt Zorn, MD,John J. Bauer, MD,Judd W. Moul, MD

July 1st 1999

Breast Cancer Prevention: The Role of Antiestrogens

BySusan E. Fugate, PharmD,Andrea S. Franks, PharmD, BCPS

July 1st 1999

The Impact of HMOs on Hospital Use and Cost? A Matter of Interpretation

ByDarrell J. Gaskin, PhD,John Kralewski, PhD

July 1st 1999

Trending on AJMC

In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison

ASH 2025 Offers Data That Could Make Novel Therapies More Accessible

Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss

52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV

As Milestone Nears, an Early Investigator Reflects on Lessons of Imatinib

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.